Mizner Bioscience releases anti-anxiety drug
The generic medication is FDA-approved for dogs at least 6 months old.
Elanco Animal Health’s anti-anxiety medication Clomicalm (clomipramine hydrochloride) has a generic competitor.
Mizner Bioscience, a privately held, Miami-based veterinary drug manufacturer, reported earning U.S. Food and Drug Administration approval of Clomipramine Hydrochloride Tablets, the company’s first product. The prescription medication is indicated for the treatment of separation anxiety in dogs at least 6 months old.
The scored tablets come in doses of 5, 20, 40 and 80 milligrams and are packaged in color-coded, 30-count bottles.
Mizner Bioscience promotes itself as a developer of generic drugs made for dogs, cats and horses.
“We are excited to launch our first of many generic drugs for the animal space,” CEO Bob Edwards said. “Generic drugs have been part of the human health system for decades, helping to lower the cost of treatment significantly. FDA-approved generic alternatives offer animal health professionals alternatives to costly medications making it more affordable for pet parents.”